I2I market assessment for epileptic seizure prediction

将进行一项市场研究，以评估一种名为GenericPred的用于癫痫发作预测的新方法商业化的可行性。GenericPred是一种用于时间序列预测的数学算法，适用于医学、计算机科学、环境科学和经济学等多个领域。GenericPred具有高度适应性、一致性和计算效率高的优点。在一个潜在的应用中，这种新方法被用来预测癫痫发作的可能发作。每100个加拿大人中就有1人患有癫痫，全球人口中有近1%患有癫痫。脑电图（EEG）读数记录大脑中的电活动，使用的是附着在人头皮上的称为电极的扁平圆盘。将GenericPred方法应用于连续脑电图数据时，可以准确预测癫痫发作的发生时间。将该方法应用于21例癫痫病人的脑电图数据进行评估；GenericPred方法在预测癫痫发作前17分钟达到100%的灵敏度和特异性。这种方法有可能被纳入健康监测或预警系统的一部分，以提供其他类型的严重健康事件（如心脏病发作和中风）的预先指示。

A market study will be conducted to assess the viability of commercializing a novel method called GenericPred for epileptic seizure prediction. GenericPred is a mathematical algorithm for time series prediction and is applicable to a variety of fields including medicine, computer science, environmental science and economics. GenericPred has the advantage of being highly adaptable, consistent and computationally efficient. In one potential application, this novel method is used to predict the likely onset of epileptic seizures. Epilepsy afflicts 1 in 100 Canadians and nearly 1% of the global population. Electroencephalogram (EEG) readings record the electrical activity in the brain using flat discs called electrodes that are attached to a person's scalp. When the GenericPred method is applied to continuous EEG data, it can accurately predict when an epileptic seizure will occur. This novel method was evaluated by applying it to pre-recorded EEG data from 21 epileptic patients; the GenericPred method attained an accuracy level with 100% sensitivity and specificity for the prediction of epileptic seizures up to 17 minutes in advance. This method may have the potential to be incorporated as part of a health monitoring or warning system to provide an advance indication of other types of serious health events, such as heart attack and stroke. The ability to predict the onset of a seizure allows for epileptic patients to prepare accordingly to maximize their safety. Devices designed to warn patients of an approaching seizure allows patients to avoid potentially dangerous activities and works toward achieving an enhanced sense of normalcy in their lives. According to a Global Business Intelligence (GBI) Research report, the epilepsy therapeutics market value in eight major countries (United States, Canada, France, Germany, Italy, Spain, United Kingdom, Japan) is expected to grow from $3.4 billion in 2012 to $4.5 billion by 2019. This technology offers a potential innovative solution to assist those suffering from epilepsy to more effectively manage their seizures and to increase Canada's presence in the epileptic therapeutic market.